<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>NZW x BXSB F1 (W/B F1) male mice develop systemic <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>-like disease, and several autoantibodies, circulating immune complexes, and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> become apparent </plain></SENT>
<SENT sid="1" pm="."><plain>The abnormally high incidence of degenerative coronary <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> with <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> due to the presence of both platelet-associated antibodies and circulating antiplatelet antibodies in this animal has been reported </plain></SENT>
<SENT sid="2" pm="."><plain>We found that W/B F1 male mice produced autoantibodies against <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> (aCL) and that the titer of aCL increases with age </plain></SENT>
<SENT sid="3" pm="."><plain>aCL from W/B F1 male mice were mainly IgG and binding activity to <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> was aCL-cofactor (beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (beta 2-GPI)) dependent </plain></SENT>
<SENT sid="4" pm="."><plain>We developed monoclonal aCL from these animals and examined specificity of the autoantibodies </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the mAb used reacted with the negatively charged <z:chebi fb="1" ids="16247">phospholipids</z:chebi>, <z:chebi fb="0" ids="28494">cardiolipin</z:chebi>, phosphatidylserine, and phosphatidylinositol, and some reacted with platelets and DNA </plain></SENT>
<SENT sid="6" pm="."><plain>The addition of human or mouse beta 2-GPI enhanced the titer for monoclonal aCL from the W/B F1 mice </plain></SENT>
<SENT sid="7" pm="."><plain>From the results of competitive inhibition enzyme immunoassay with monoclonal aCL and purified beta 2-GPI, aCL from the W/B F1 mice recognized the complex of CL and beta 2-GPI </plain></SENT>
<SENT sid="8" pm="."><plain>The W/B F1 male mouse may be an appropriate model for use in studies on the pathologic significance of aCL in patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
</text></document>